Trial intelligence / Profile preview

Effect of Erythropoietin on Bone Union in Tibiofibular Fracture

IRCT20171224038039N1Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Jan 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of erythropoietin in Tibiofibular fracture, sponsored by Zahedan University of Medical Sciences. Started Jan 2018; status: completed.

02

Drugs

erythropoietin
03

Conditions

Tibiofibular fracture

Beyond the preview

Go deeper on IRCT20171224038039N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171224038039N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call